| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5879667 | Journal of Pain and Symptom Management | 2015 | 6 Pages |
Abstract
The use of mHealth technology is a feasible and acceptable option for delivery of PCST for patients with cancer. This delivery mode is likely to dramatically increase intervention access for cancer patients with pain compared to traditional in-person delivery. Preliminary data also suggest that the program is likely to produce pretreatment to post-treatment decreases in pain and other important outcomes.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Tamara J. PhD, Amy P. MD, PhD, Sara N. MA, Sarah A. PhD, Anava A. MA, Greg P. PhD, Francis J. PhD,